Effects of Descurainia sophia on Oxidative Stress Markers and Thirst Alleviation in Hemodialysis Patients: A Randomized Double-Blinded Placebo-Controlled Cross-Over Clinical Trial
Background. Patients undergoing hemodialysis (HD) are regularly exposed to oxidative stress and inflammation and may suffer from thirst distress with no definitive treatment to address these complications. Descurainia sophia (DS) has been used to alleviate thirst in traditional Persian medicine. Thi...
Gespeichert in:
| Veröffentlicht in: | Evidence-based complementary and alternative medicine 2022, Vol.2022, p.2001441-12 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 12 |
|---|---|
| container_issue | |
| container_start_page | 2001441 |
| container_title | Evidence-based complementary and alternative medicine |
| container_volume | 2022 |
| creator | Asgharpour, Masoumeh Enayati, Noora Rezaei Sadrabadi, Mohammad Mohamadi Afrakati, Mana Khavandegar, Armin Mardi, Parham Alirezaei, Amirhesam Taherinia, Ali Bakhtiyari, Mahmood |
| description | Background. Patients undergoing hemodialysis (HD) are regularly exposed to oxidative stress and inflammation and may suffer from thirst distress with no definitive treatment to address these complications. Descurainia sophia (DS) has been used to alleviate thirst in traditional Persian medicine. This study aimed to assess the effectiveness of DS on oxidation factors and thirst score in HD patients. Methods. This study was conducted on fifty-three HD patients referred to Tehran Shahid Modarres hospital. The patients were randomly divided into two groups: Group 1 received DS for six weeks, then underwent four weeks of washout period followed by six weeks of placebo treatment, while group 2 received placebo initially followed by treatment with DS. Biochemistry, malondialdehyde (MDA), and total antioxidant capacity (TAC) were measured in four phases: at the beginning, before washout, after washout, and at the end of the study. The patient’s body weight was recorded at the start of each session to assess interdialytic weight gain. Thirst scores also were measured using a visual analog scale. Results. A total of 53 patients, including 23 (43.4%) male and 30 (56.6%) female subjects, were included in the study. The results showed a reduction in thirst score (p=0.001), cholesterol levels (p=0.046), triglycerides (0.003), and MDA (p |
| doi_str_mv | 10.1155/2022/2001441 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9652079</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2737472714</sourcerecordid><originalsourceid>FETCH-LOGICAL-c405t-2dccc4a86a489d4ffe5be8318b6eb49de636cf2e3f6268113f66aa3cbc9e9e993</originalsourceid><addsrcrecordid>eNp9kl2L1DAUhoso7rp657UEvBG0mqRp0u6FMHZXV1iZRUfwLqTpqZM1TcakHV3_ln_QlBkH9UICOfl4zkvenJNlDwl-TkhZvqCY0jRhwhi5lR0TwUjOaFXdPqzFp6PsXozXGNNaCHE3Oyp4UYmixMfZz_O-Bz1G5Ht0BlFPQRlnFIp-s07BO7T8bjo1mi2gD2OAGNE7Fb5AiEi5Dq3WJsQRLayFrUlU4o1DFzD4zih7E01EV-kY3BhP0QK9Tzl-MD-gQ2d-ai3kr6xxXdpeWaWh9Xnj3Rh8kutQE3yM-XILATWJMlpZtApJ9n52p1c2woN9PMk-vj5fNRf55fLN22ZxmWuGyzGnndaaqYorVtUdSz7LFqqCVC2HltUd8ILrnkLRc8orQlLkShW61TWkURcn2cud7mZqB-h0chGUlZtgBhVupFdG_n3jzFp-9ltZ85JiMQs82QsE_3WCOMrBRA3WKgd-ipKKQjBBBWEJffwPeu2n4JK9mSo5Z7jGiXq2o_T8NwH6w2MIlnM3yLkb5L4bEv7oTwMH-Hf5E_B0B6xTFdQ383-5X9NzwMg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2735664090</pqid></control><display><type>article</type><title>Effects of Descurainia sophia on Oxidative Stress Markers and Thirst Alleviation in Hemodialysis Patients: A Randomized Double-Blinded Placebo-Controlled Cross-Over Clinical Trial</title><source>Wiley Online Library Open Access</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>PubMed Central Open Access</source><creator>Asgharpour, Masoumeh ; Enayati, Noora ; Rezaei Sadrabadi, Mohammad ; Mohamadi Afrakati, Mana ; Khavandegar, Armin ; Mardi, Parham ; Alirezaei, Amirhesam ; Taherinia, Ali ; Bakhtiyari, Mahmood</creator><contributor>Hashempur, Mohammad Hashem</contributor><creatorcontrib>Asgharpour, Masoumeh ; Enayati, Noora ; Rezaei Sadrabadi, Mohammad ; Mohamadi Afrakati, Mana ; Khavandegar, Armin ; Mardi, Parham ; Alirezaei, Amirhesam ; Taherinia, Ali ; Bakhtiyari, Mahmood ; Hashempur, Mohammad Hashem</creatorcontrib><description>Background. Patients undergoing hemodialysis (HD) are regularly exposed to oxidative stress and inflammation and may suffer from thirst distress with no definitive treatment to address these complications. Descurainia sophia (DS) has been used to alleviate thirst in traditional Persian medicine. This study aimed to assess the effectiveness of DS on oxidation factors and thirst score in HD patients. Methods. This study was conducted on fifty-three HD patients referred to Tehran Shahid Modarres hospital. The patients were randomly divided into two groups: Group 1 received DS for six weeks, then underwent four weeks of washout period followed by six weeks of placebo treatment, while group 2 received placebo initially followed by treatment with DS. Biochemistry, malondialdehyde (MDA), and total antioxidant capacity (TAC) were measured in four phases: at the beginning, before washout, after washout, and at the end of the study. The patient’s body weight was recorded at the start of each session to assess interdialytic weight gain. Thirst scores also were measured using a visual analog scale. Results. A total of 53 patients, including 23 (43.4%) male and 30 (56.6%) female subjects, were included in the study. The results showed a reduction in thirst score (p=0.001), cholesterol levels (p=0.046), triglycerides (0.003), and MDA (p<0.001) following the four-week administration of DS treatment in HD patients. The mean levels of TAC were increased (p<0.001), and calcium, as well as Na+, remained unchanged (p>0.05). Also, a significant decrease in the patient’s weight was observed (p value <0.001). This effect persisted after shifting to a placebo. However, the two groups had no significant difference (p value = 0.539). Conclusion. DS powder-mixed syrup may benefit HD patients by facilitating free radical scavenging and alleviating thirst distress with minimal adverse effects. The seeds could therefore be utilized as a complementary therapy for hemodialysis patients.</description><identifier>ISSN: 1741-427X</identifier><identifier>EISSN: 1741-4288</identifier><identifier>DOI: 10.1155/2022/2001441</identifier><identifier>PMID: 36387350</identifier><language>eng</language><publisher>United States: Hindawi</publisher><subject>Antioxidants ; Body weight ; Body weight gain ; Cholesterol ; Chronic illnesses ; Clinical trials ; Descurainia sophia ; Fatty acids ; Free radicals ; Hemodialysis ; Herbal medicine ; Hospitals ; Irritable bowel syndrome ; Medicine ; Nosocomial infections ; Oxidative stress ; Patients ; Placebos ; Reflexology ; Restless legs syndrome ; Seeds ; Thirst ; Triglycerides</subject><ispartof>Evidence-based complementary and alternative medicine, 2022, Vol.2022, p.2001441-12</ispartof><rights>Copyright © 2022 Masoumeh Asgharpour et al.</rights><rights>Copyright © 2022 Masoumeh Asgharpour et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0</rights><rights>Copyright © 2022 Masoumeh Asgharpour et al. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c405t-2dccc4a86a489d4ffe5be8318b6eb49de636cf2e3f6268113f66aa3cbc9e9e993</cites><orcidid>0000-0001-9720-6723 ; 0000-0002-4761-8938 ; 0000-0002-1216-7671</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652079/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652079/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,4010,27900,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36387350$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Hashempur, Mohammad Hashem</contributor><creatorcontrib>Asgharpour, Masoumeh</creatorcontrib><creatorcontrib>Enayati, Noora</creatorcontrib><creatorcontrib>Rezaei Sadrabadi, Mohammad</creatorcontrib><creatorcontrib>Mohamadi Afrakati, Mana</creatorcontrib><creatorcontrib>Khavandegar, Armin</creatorcontrib><creatorcontrib>Mardi, Parham</creatorcontrib><creatorcontrib>Alirezaei, Amirhesam</creatorcontrib><creatorcontrib>Taherinia, Ali</creatorcontrib><creatorcontrib>Bakhtiyari, Mahmood</creatorcontrib><title>Effects of Descurainia sophia on Oxidative Stress Markers and Thirst Alleviation in Hemodialysis Patients: A Randomized Double-Blinded Placebo-Controlled Cross-Over Clinical Trial</title><title>Evidence-based complementary and alternative medicine</title><addtitle>Evid Based Complement Alternat Med</addtitle><description>Background. Patients undergoing hemodialysis (HD) are regularly exposed to oxidative stress and inflammation and may suffer from thirst distress with no definitive treatment to address these complications. Descurainia sophia (DS) has been used to alleviate thirst in traditional Persian medicine. This study aimed to assess the effectiveness of DS on oxidation factors and thirst score in HD patients. Methods. This study was conducted on fifty-three HD patients referred to Tehran Shahid Modarres hospital. The patients were randomly divided into two groups: Group 1 received DS for six weeks, then underwent four weeks of washout period followed by six weeks of placebo treatment, while group 2 received placebo initially followed by treatment with DS. Biochemistry, malondialdehyde (MDA), and total antioxidant capacity (TAC) were measured in four phases: at the beginning, before washout, after washout, and at the end of the study. The patient’s body weight was recorded at the start of each session to assess interdialytic weight gain. Thirst scores also were measured using a visual analog scale. Results. A total of 53 patients, including 23 (43.4%) male and 30 (56.6%) female subjects, were included in the study. The results showed a reduction in thirst score (p=0.001), cholesterol levels (p=0.046), triglycerides (0.003), and MDA (p<0.001) following the four-week administration of DS treatment in HD patients. The mean levels of TAC were increased (p<0.001), and calcium, as well as Na+, remained unchanged (p>0.05). Also, a significant decrease in the patient’s weight was observed (p value <0.001). This effect persisted after shifting to a placebo. However, the two groups had no significant difference (p value = 0.539). Conclusion. DS powder-mixed syrup may benefit HD patients by facilitating free radical scavenging and alleviating thirst distress with minimal adverse effects. The seeds could therefore be utilized as a complementary therapy for hemodialysis patients.</description><subject>Antioxidants</subject><subject>Body weight</subject><subject>Body weight gain</subject><subject>Cholesterol</subject><subject>Chronic illnesses</subject><subject>Clinical trials</subject><subject>Descurainia sophia</subject><subject>Fatty acids</subject><subject>Free radicals</subject><subject>Hemodialysis</subject><subject>Herbal medicine</subject><subject>Hospitals</subject><subject>Irritable bowel syndrome</subject><subject>Medicine</subject><subject>Nosocomial infections</subject><subject>Oxidative stress</subject><subject>Patients</subject><subject>Placebos</subject><subject>Reflexology</subject><subject>Restless legs syndrome</subject><subject>Seeds</subject><subject>Thirst</subject><subject>Triglycerides</subject><issn>1741-427X</issn><issn>1741-4288</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>RHX</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kl2L1DAUhoso7rp657UEvBG0mqRp0u6FMHZXV1iZRUfwLqTpqZM1TcakHV3_ln_QlBkH9UICOfl4zkvenJNlDwl-TkhZvqCY0jRhwhi5lR0TwUjOaFXdPqzFp6PsXozXGNNaCHE3Oyp4UYmixMfZz_O-Bz1G5Ht0BlFPQRlnFIp-s07BO7T8bjo1mi2gD2OAGNE7Fb5AiEi5Dq3WJsQRLayFrUlU4o1DFzD4zih7E01EV-kY3BhP0QK9Tzl-MD-gQ2d-ai3kr6xxXdpeWaWh9Xnj3Rh8kutQE3yM-XILATWJMlpZtApJ9n52p1c2woN9PMk-vj5fNRf55fLN22ZxmWuGyzGnndaaqYorVtUdSz7LFqqCVC2HltUd8ILrnkLRc8orQlLkShW61TWkURcn2cud7mZqB-h0chGUlZtgBhVupFdG_n3jzFp-9ltZ85JiMQs82QsE_3WCOMrBRA3WKgd-ipKKQjBBBWEJffwPeu2n4JK9mSo5Z7jGiXq2o_T8NwH6w2MIlnM3yLkb5L4bEv7oTwMH-Hf5E_B0B6xTFdQ383-5X9NzwMg</recordid><startdate>2022</startdate><enddate>2022</enddate><creator>Asgharpour, Masoumeh</creator><creator>Enayati, Noora</creator><creator>Rezaei Sadrabadi, Mohammad</creator><creator>Mohamadi Afrakati, Mana</creator><creator>Khavandegar, Armin</creator><creator>Mardi, Parham</creator><creator>Alirezaei, Amirhesam</creator><creator>Taherinia, Ali</creator><creator>Bakhtiyari, Mahmood</creator><general>Hindawi</general><general>Hindawi Limited</general><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88G</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M2M</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PIMPY</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-9720-6723</orcidid><orcidid>https://orcid.org/0000-0002-4761-8938</orcidid><orcidid>https://orcid.org/0000-0002-1216-7671</orcidid></search><sort><creationdate>2022</creationdate><title>Effects of Descurainia sophia on Oxidative Stress Markers and Thirst Alleviation in Hemodialysis Patients: A Randomized Double-Blinded Placebo-Controlled Cross-Over Clinical Trial</title><author>Asgharpour, Masoumeh ; Enayati, Noora ; Rezaei Sadrabadi, Mohammad ; Mohamadi Afrakati, Mana ; Khavandegar, Armin ; Mardi, Parham ; Alirezaei, Amirhesam ; Taherinia, Ali ; Bakhtiyari, Mahmood</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c405t-2dccc4a86a489d4ffe5be8318b6eb49de636cf2e3f6268113f66aa3cbc9e9e993</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Antioxidants</topic><topic>Body weight</topic><topic>Body weight gain</topic><topic>Cholesterol</topic><topic>Chronic illnesses</topic><topic>Clinical trials</topic><topic>Descurainia sophia</topic><topic>Fatty acids</topic><topic>Free radicals</topic><topic>Hemodialysis</topic><topic>Herbal medicine</topic><topic>Hospitals</topic><topic>Irritable bowel syndrome</topic><topic>Medicine</topic><topic>Nosocomial infections</topic><topic>Oxidative stress</topic><topic>Patients</topic><topic>Placebos</topic><topic>Reflexology</topic><topic>Restless legs syndrome</topic><topic>Seeds</topic><topic>Thirst</topic><topic>Triglycerides</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Asgharpour, Masoumeh</creatorcontrib><creatorcontrib>Enayati, Noora</creatorcontrib><creatorcontrib>Rezaei Sadrabadi, Mohammad</creatorcontrib><creatorcontrib>Mohamadi Afrakati, Mana</creatorcontrib><creatorcontrib>Khavandegar, Armin</creatorcontrib><creatorcontrib>Mardi, Parham</creatorcontrib><creatorcontrib>Alirezaei, Amirhesam</creatorcontrib><creatorcontrib>Taherinia, Ali</creatorcontrib><creatorcontrib>Bakhtiyari, Mahmood</creatorcontrib><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health & Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Evidence-based complementary and alternative medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Asgharpour, Masoumeh</au><au>Enayati, Noora</au><au>Rezaei Sadrabadi, Mohammad</au><au>Mohamadi Afrakati, Mana</au><au>Khavandegar, Armin</au><au>Mardi, Parham</au><au>Alirezaei, Amirhesam</au><au>Taherinia, Ali</au><au>Bakhtiyari, Mahmood</au><au>Hashempur, Mohammad Hashem</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of Descurainia sophia on Oxidative Stress Markers and Thirst Alleviation in Hemodialysis Patients: A Randomized Double-Blinded Placebo-Controlled Cross-Over Clinical Trial</atitle><jtitle>Evidence-based complementary and alternative medicine</jtitle><addtitle>Evid Based Complement Alternat Med</addtitle><date>2022</date><risdate>2022</risdate><volume>2022</volume><spage>2001441</spage><epage>12</epage><pages>2001441-12</pages><issn>1741-427X</issn><eissn>1741-4288</eissn><abstract>Background. Patients undergoing hemodialysis (HD) are regularly exposed to oxidative stress and inflammation and may suffer from thirst distress with no definitive treatment to address these complications. Descurainia sophia (DS) has been used to alleviate thirst in traditional Persian medicine. This study aimed to assess the effectiveness of DS on oxidation factors and thirst score in HD patients. Methods. This study was conducted on fifty-three HD patients referred to Tehran Shahid Modarres hospital. The patients were randomly divided into two groups: Group 1 received DS for six weeks, then underwent four weeks of washout period followed by six weeks of placebo treatment, while group 2 received placebo initially followed by treatment with DS. Biochemistry, malondialdehyde (MDA), and total antioxidant capacity (TAC) were measured in four phases: at the beginning, before washout, after washout, and at the end of the study. The patient’s body weight was recorded at the start of each session to assess interdialytic weight gain. Thirst scores also were measured using a visual analog scale. Results. A total of 53 patients, including 23 (43.4%) male and 30 (56.6%) female subjects, were included in the study. The results showed a reduction in thirst score (p=0.001), cholesterol levels (p=0.046), triglycerides (0.003), and MDA (p<0.001) following the four-week administration of DS treatment in HD patients. The mean levels of TAC were increased (p<0.001), and calcium, as well as Na+, remained unchanged (p>0.05). Also, a significant decrease in the patient’s weight was observed (p value <0.001). This effect persisted after shifting to a placebo. However, the two groups had no significant difference (p value = 0.539). Conclusion. DS powder-mixed syrup may benefit HD patients by facilitating free radical scavenging and alleviating thirst distress with minimal adverse effects. The seeds could therefore be utilized as a complementary therapy for hemodialysis patients.</abstract><cop>United States</cop><pub>Hindawi</pub><pmid>36387350</pmid><doi>10.1155/2022/2001441</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0001-9720-6723</orcidid><orcidid>https://orcid.org/0000-0002-4761-8938</orcidid><orcidid>https://orcid.org/0000-0002-1216-7671</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1741-427X |
| ispartof | Evidence-based complementary and alternative medicine, 2022, Vol.2022, p.2001441-12 |
| issn | 1741-427X 1741-4288 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9652079 |
| source | Wiley Online Library Open Access; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection; PubMed Central Open Access |
| subjects | Antioxidants Body weight Body weight gain Cholesterol Chronic illnesses Clinical trials Descurainia sophia Fatty acids Free radicals Hemodialysis Herbal medicine Hospitals Irritable bowel syndrome Medicine Nosocomial infections Oxidative stress Patients Placebos Reflexology Restless legs syndrome Seeds Thirst Triglycerides |
| title | Effects of Descurainia sophia on Oxidative Stress Markers and Thirst Alleviation in Hemodialysis Patients: A Randomized Double-Blinded Placebo-Controlled Cross-Over Clinical Trial |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T17%3A05%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20Descurainia%20sophia%20on%20Oxidative%20Stress%20Markers%20and%20Thirst%20Alleviation%20in%20Hemodialysis%20Patients:%20A%20Randomized%20Double-Blinded%20Placebo-Controlled%20Cross-Over%20Clinical%20Trial&rft.jtitle=Evidence-based%20complementary%20and%20alternative%20medicine&rft.au=Asgharpour,%20Masoumeh&rft.date=2022&rft.volume=2022&rft.spage=2001441&rft.epage=12&rft.pages=2001441-12&rft.issn=1741-427X&rft.eissn=1741-4288&rft_id=info:doi/10.1155/2022/2001441&rft_dat=%3Cproquest_pubme%3E2737472714%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2735664090&rft_id=info:pmid/36387350&rfr_iscdi=true |